MRNA Total Debt
Short-term plus long-term borrowings at each quarter end, before any offset for cash.
Total Debt
Latest: $591M (2026Q2)
| Period | Value |
|---|---|
| 2024Q4 | $0.00 |
| 2025Q4 | $590M |
| 2026Q1 | $590M |
| 2026Q2 | $591M |
Other MRNA Charts
More quarter-by-quarter fundamentals for Moderna, Inc.
1 / 9
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
Cumulative FCF
Shares Outstanding
Total Assets
Rule of 40
Healthcare Comparison
1 / 3
Latest Total Debt: $591M (2026Q2).
Across the 4 quarters from 2024Q4 to 2026Q2, Total Debt ranged from $0.00 in 2024Q4 to $591M in 2026Q2.